477 related articles for article (PubMed ID: 18294743)
21. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-linked immunosorbent assay for detection of serum antibody in children vaccinated with Japanese encephalitis vaccine.
Okamoto Y; Okuno Y; Yamada A; Baba K; Yabuuchi H
Biken J; 1986 Dec; 29(3-4):57-62. PubMed ID: 3619879
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity.
Reisler RB; Danner DK; Gibbs PH
Vaccine; 2010 Mar; 28(12):2436-41. PubMed ID: 20060946
[TBL] [Abstract][Full Text] [Related]
24. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.
Khan SA; Kakati S; Dutta P; Chowdhury P; Borah J; Topno R; Jadhav SM; Mohapatra PK; Mahanta J; Gupte MD
Indian J Med Res; 2016 Dec; 144(6):886-892. PubMed ID: 28474625
[TBL] [Abstract][Full Text] [Related]
26. The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.
Kwon HJ; Lee SY; Kim KH; Kim DS; Cha SH; Jo DS; Kang JH
J Korean Med Sci; 2015 May; 30(5):612-6. PubMed ID: 25931793
[TBL] [Abstract][Full Text] [Related]
27. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
28. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.
Schuller E; Jilma B; Voicu V; Golor G; Kollaritsch H; Kaltenböck A; Klade C; Tauber E
Vaccine; 2008 Aug; 26(34):4382-6. PubMed ID: 18599165
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
[TBL] [Abstract][Full Text] [Related]
30. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51.
Dubischar-Kastner K; Eder S; Buerger V; Gartner-Woelfl G; Kaltenboeck A; Schuller E; Tauber E; Klade C
Vaccine; 2010 Jul; 28(32):5197-202. PubMed ID: 20541581
[TBL] [Abstract][Full Text] [Related]
31. Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
Bouckenooghe A; Bailleux F; Feroldi E
Hum Vaccin Immunother; 2019; 15(1):72-79. PubMed ID: 30230947
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
[TBL] [Abstract][Full Text] [Related]
33. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC
Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
35. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.
Feroldi E; Pancharoen C; Kosalaraksa P; Watanaveeradej V; Phirangkul K; Capeding MR; Boaz M; Gailhardou S; Bouckenooghe A
Hum Vaccin Immunother; 2012 Jul; 8(7):929-37. PubMed ID: 22777096
[TBL] [Abstract][Full Text] [Related]
36. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
Sricharoenchai S; Lapphra K; Chuenkitmongkol S; Phongsamart W; Bouckenooghe A; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Feb; 36(2):e45-e47. PubMed ID: 27846060
[TBL] [Abstract][Full Text] [Related]
38. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com.
Tandan JB; Ohrr H; Sohn YM; Yoksan S; Ji M; Nam CM; Halstead SB
Vaccine; 2007 Jun; 25(27):5041-5. PubMed ID: 17521781
[TBL] [Abstract][Full Text] [Related]
39. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
40. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
